You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Dengue Vaccine Market By Key Players (Sanofi, GeneOne Life Sciences, U.S NIH, Takeda Pharmaceuticals) Based on 2020 COVID-19 Worldwide Spread

The report on the Global Dengue Vaccine Market has published by Lexis Business Insights. The report provides the client the latest trending insights about the Dengue Vaccine market. You will find in the report include market value and growth rate, size, production consumption and gross margin, pricings, and other influential factors. Along with these you will get detailed information about all the distributors, suppliers and retailers of the Dengue Vaccine market in the report. The competitive scenario of all the industry players are mentioned in-detail in the report. Due to the pandemic the market players have strategically changed their business plans.
Some of the key industry players that are operating in the Dengue Vaccine market are:
Vabiotec

Merck Sharp & Dohme

Takeda Pharmaceuticals

GeneOne Life Sciences

U.S NIH

Sanofi

GlaxoSmithKline

Medigen Biologics

Panacea Biotec

Sun Pharmaceutical

Through the month of the analysis, research analysts predicted that the Dengue Vaccine market reached XX million dollars in 2019 and the market demand will reach XX million dollars by 2026. During the forecast period 2020 to 2026 the expected CAGR is XX%. The increasing investments in the research and development activities and the rising technological advancements in the Dengue Vaccine market, increasing the market growth.
Due to the increase of pandemic world-wide several market issues has generated around the world. Such as, economic crisis in various regions along with loss of employment.
The questions that are answered in the report:
What are the challenges for the Dengue Vaccine market created by the outbreak of the global pandemic?

What are the drivers that are shaping the Dengue Vaccine market?

What are the top opportunities that are currently ruling the market?

What are the segments of the Dengue Vaccine market that are given in the report?

What are the developing regions in the Dengue Vaccine market?

Overall industries are struggling on the global platform to revive the markets. It has been observed that through the pandemic almost every market domain has been impacted.
Market Segmentation
The Dengue Vaccine market regional presence is showcased in five major regions Europe, North America, Latin America, Asia Pacific, and the Middle East and Africa. In the report, the country-level analysis is also provided.
The Dengue Vaccine market is segmented into Product Types:
CYD-TDV

DENVax or TAK-003

TetraVax-DV

TDENV PIV

V180

DNA vaccines

The Dengue Vaccine market is segmented into By End User/Application:
Government institutions

Hospitals

NGOs

The major points that are covered in the report:
Overview:
In this section, the global Dengue Vaccine Market definition is given, with an overview of the report in order to provide a board outlook about the nature and contents of the research study.
Strategies Analysis of Industry Players:
This Strategic Analysis will help to gain competitive advantage over their competitors to the market players.
Essential Market Trends:
Depth analysis of the market’s latest and future trends is provided in this section.
Market Forecasts:
In this segment, accurate and validated values of the total market size in terms of value and volume have provided by the research analyst. Also the report include production, consumption, sales, and other forecasts for the global Dengue Vaccine Market.
Regional Analysis:
In the global Dengue Vaccine market report major five regions and its countries have been covered. Market players will have estimates about the untapped regional markets and other benefits with the help of this analysis.
Segment Analysis:
Accurate and reliable foretell about the market share of the essential sections of the Dengue Vaccine market is provided.
Regional Segmentation
North America

Latin America

Europe

Asia Pacific

Middle East and Africa

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Dengue Vaccine Market Share by Type (2020-2026)
1.5.2 CYD-TDV
1.5.3 DENVax or TAK-003
1.5.4 TetraVax-DV
1.5.5 TDENV PIV
1.5.6 V180
1.5.7 DNA vaccines
1.6 Market by Application
1.6.1 Global Dengue Vaccine Market Share by Application (2020-2026)
1.6.2 Government institutions
1.6.3 Hospitals
1.6.4 NGOs
1.7 Dengue Vaccine Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Dengue Vaccine Industry Development

2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19

3 Value Chain of Dengue Vaccine Market
3.1 Value Chain Status
3.2 Dengue Vaccine Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Dengue Vaccine
3.2.3 Labor Cost of Dengue Vaccine
3.2.3.1 Labor Cost of Dengue Vaccine Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19

4 Players Profiles
4.1 Vabiotec
4.1.1 Vabiotec Basic Information
4.1.2 Dengue Vaccine Product Profiles, Application and Specification
4.1.3 Vabiotec Dengue Vaccine Market Performance (2015-2020)
4.1.4 Vabiotec Business Overview
4.2 Merck Sharp & Dohme
4.2.1 Merck Sharp & Dohme Basic Information
4.2.2 Dengue Vaccine Product Profiles, Application and Specification
4.2.3 Merck Sharp & Dohme Dengue Vaccine Market Performance (2015-2020)
4.2.4 Merck Sharp & Dohme Business Overview
4.3 Takeda Pharmaceuticals
4.3.1 Takeda Pharmaceuticals Basic Information
4.3.2 Dengue Vaccine Product Profiles, Application and Specification
4.3.3 Takeda Pharmaceuticals Dengue Vaccine Market Performance (2015-2020)
4.3.4 Takeda Pharmaceuticals Business Overview
4.4 GeneOne Life Sciences
4.4.1 GeneOne Life Sciences Basic Information
4.4.2 Dengue Vaccine Product Profiles, Application and Specification
4.4.3 GeneOne Life Sciences Dengue Vaccine Market Performance (2015-2020)
4.4.4 GeneOne Life Sciences Business Overview
4.5 U.S NIH
4.5.1 U.S NIH Basic Information
4.5.2 Dengue Vaccine Product Profiles, Application and Specification
4.5.3 U.S NIH Dengue Vaccine Market Performance (2015-2020)
4.5.4 U.S NIH Business Overview
4.6 Sanofi
4.6.1 Sanofi Basic Information
4.6.2 Dengue Vaccine Product Profiles, Application and Specification
4.6.3 Sanofi Dengue Vaccine Market Performance (2015-2020)
4.6.4 Sanofi Business Overview
4.7 GlaxoSmithKline
4.7.1 GlaxoSmithKline Basic Information
4.7.2 Dengue Vaccine Product Profiles, Application and Specification
4.7.3 GlaxoSmithKline Dengue Vaccine Market Performance (2015-2020)
4.7.4 GlaxoSmithKline Business Overview
4.8 Medigen Biologics
4.8.1 Medigen Biologics Basic Information
4.8.2 Dengue Vaccine Product Profiles, Application and Specification
4.8.3 Medigen Biologics Dengue Vaccine Market Performance (2015-2020)
4.8.4 Medigen Biologics Business Overview
4.9 Panacea Biotec
4.9.1 Panacea Biotec Basic Information
4.9.2 Dengue Vaccine Product Profiles, Application and Specification
4.9.3 Panacea Biotec Dengue Vaccine Market Performance (2015-2020)
4.9.4 Panacea Biotec Business Overview
4.10 Sun Pharmaceutical
4.10.1 Sun Pharmaceutical Basic Information
4.10.2 Dengue Vaccine Product Profiles, Application and Specification
4.10.3 Sun Pharmaceutical Dengue Vaccine Market Performance (2015-2020)
4.10.4 Sun Pharmaceutical Business Overview

5 Global Dengue Vaccine Market Analysis by Regions
5.1 Global Dengue Vaccine Sales, Revenue and Market Share by Regions
5.1.1 Global Dengue Vaccine Sales by Regions (2015-2020)
5.1.2 Global Dengue Vaccine Revenue by Regions (2015-2020)
5.2 North America Dengue Vaccine Sales and Growth Rate (2015-2020)
5.3 Europe Dengue Vaccine Sales and Growth Rate (2015-2020)
5.4 Asia-Pacific Dengue Vaccine Sales and Growth Rate (2015-2020)
5.5 Middle East and Africa Dengue Vaccine Sales and Growth Rate (2015-2020)
5.6 South America Dengue Vaccine Sales and Growth Rate (2015-2020)

6 North America Dengue Vaccine Market Analysis by Countries
6.1 North America Dengue Vaccine Sales, Revenue and Market Share by Countries
6.1.1 North America Dengue Vaccine Sales by Countries (2015-2020)
6.1.2 North America Dengue Vaccine Revenue by Countries (2015-2020)
6.1.3 North America Dengue Vaccine Market Under COVID-19
6.2 United States Dengue Vaccine Sales and Growth Rate (2015-2020)
6.2.1 United States Dengue Vaccine Market Under COVID-19
6.3 Canada Dengue Vaccine Sales and Growth Rate (2015-2020)
6.4 Mexico Dengue Vaccine Sales and Growth Rate (2015-2020)

7 Europe Dengue Vaccine Market Analysis by Countries
7.1 Europe Dengue Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Europe Dengue Vaccine Sales by Countries (2015-2020)
7.1.2 Europe Dengue Vaccine Revenue by Countries (2015-2020)
7.1.3 Europe Dengue Vaccine Market Under COVID-19
7.2 Germany Dengue Vaccine Sales and Growth Rate (2015-2020)
7.2.1 Germany Dengue Vaccine Market Under COVID-19
7.3 UK Dengue Vaccine Sales and Growth Rate (2015-2020)
7.3.1 UK Dengue Vaccine Market Under COVID-19
7.4 France Dengue Vaccine Sales and Growth Rate (2015-2020)
7.4.1 France Dengue Vaccine Market Under COVID-19
7.5 Italy Dengue Vaccine Sales and Growth Rate (2015-2020)
7.5.1 Italy Dengue Vaccine Market Under COVID-19
7.6 Spain Dengue Vaccine Sales and Growth Rate (2015-2020)
7.6.1 Spain Dengue Vaccine Market Under COVID-19
7.7 Russia Dengue Vaccine Sales and Growth Rate (2015-2020)
7.7.1 Russia Dengue Vaccine Market Under COVID-19

8 Asia-Pacific Dengue Vaccine Market Analysis by Countries
8.1 Asia-Pacific Dengue Vaccine Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Dengue Vaccine Sales by Countries (2015-2020)
8.1.2 Asia-Pacific Dengue Vaccine Revenue by Countries (2015-2020)
8.1.3 Asia-Pacific Dengue Vaccine Market Under COVID-19
8.2 China Dengue Vaccine Sales and Growth Rate (2015-2020)
8.2.1 China Dengue Vaccine Market Under COVID-19
8.3 Japan Dengue Vaccine Sales and Growth Rate (2015-2020)
8.3.1 Japan Dengue Vaccine Market Under COVID-19
8.4 South Korea Dengue Vaccine Sales and Growth Rate (2015-2020)
8.4.1 South Korea Dengue Vaccine Market Under COVID-19
8.5 Australia Dengue Vaccine Sales and Growth Rate (2015-2020)
8.6 India Dengue Vaccine Sales and Growth Rate (2015-2020)
8.6.1 India Dengue Vaccine Market Under COVID-19
8.7 Southeast Asia Dengue Vaccine Sales and Growth Rate (2015-2020)
8.7.1 Southeast Asia Dengue Vaccine Market Under COVID-19

9 Middle East and Africa Dengue Vaccine Market Analysis by Countries
9.1 Middle East and Africa Dengue Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Dengue Vaccine Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Dengue Vaccine Revenue by Countries (2015-2020)
9.1.3 Middle East and Africa Dengue Vaccine Market Under COVID-19
9.2 Saudi Arabia Dengue Vaccine Sales and Growth Rate (2015-2020)
9.3 UAE Dengue Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Dengue Vaccine Sales and Growth Rate (2015-2020)
9.5 Nigeria Dengue Vaccine Sales and Growth Rate (2015-2020)
9.6 South Africa Dengue Vaccine Sales and Growth Rate (2015-2020)

10 South America Dengue Vaccine Market Analysis by Countries
10.1 South America Dengue Vaccine Sales, Revenue and Market Share by Countries
10.1.1 South America Dengue Vaccine Sales by Countries (2015-2020)
10.1.2 South America Dengue Vaccine Revenue by Countries (2015-2020)
10.1.3 South America Dengue Vaccine Market Under COVID-19
10.2 Brazil Dengue Vaccine Sales and Growth Rate (2015-2020)
10.2.1 Brazil Dengue Vaccine Market Under COVID-19
10.3 Argentina Dengue Vaccine Sales and Growth Rate (2015-2020)
10.4 Columbia Dengue Vaccine Sales and Growth Rate (2015-2020)
10.5 Chile Dengue Vaccine Sales and Growth Rate (2015-2020)

11 Global Dengue Vaccine Market Segment by Types
11.1 Global Dengue Vaccine Sales, Revenue and Market Share by Types (2015-2020)
11.1.1 Global Dengue Vaccine Sales and Market Share by Types (2015-2020)
11.1.2 Global Dengue Vaccine Revenue and Market Share by Types (2015-2020)
11.2 CYD-TDV Sales and Price (2015-2020)
11.3 DENVax or TAK-003 Sales and Price (2015-2020)
11.4 TetraVax-DV Sales and Price (2015-2020)
11.5 TDENV PIV Sales and Price (2015-2020)
11.6 V180 Sales and Price (2015-2020)
11.7 DNA vaccines Sales and Price (2015-2020)

12 Global Dengue Vaccine Market Segment by Applications
12.1 Global Dengue Vaccine Sales, Revenue and Market Share by Applications (2015-2020)
12.1.1 Global Dengue Vaccine Sales and Market Share by Applications (2015-2020)
12.1.2 Global Dengue Vaccine Revenue and Market Share by Applications (2015-2020)
12.2 Government institutions Sales, Revenue and Growth Rate (2015-2020)
12.3 Hospitals Sales, Revenue and Growth Rate (2015-2020)
12.4 NGOs Sales, Revenue and Growth Rate (2015-2020)

13 Dengue Vaccine Market Forecast by Regions (2020-2026)
13.1 Global Dengue Vaccine Sales, Revenue and Growth Rate (2020-2026)
13.2 Dengue Vaccine Market Forecast by Regions (2020-2026)
13.2.1 North America Dengue Vaccine Market Forecast (2020-2026)
13.2.2 Europe Dengue Vaccine Market Forecast (2020-2026)
13.2.3 Asia-Pacific Dengue Vaccine Market Forecast (2020-2026)
13.2.4 Middle East and Africa Dengue Vaccine Market Forecast (2020-2026)
13.2.5 South America Dengue Vaccine Market Forecast (2020-2026)
13.3 Dengue Vaccine Market Forecast by Types (2020-2026)
13.4 Dengue Vaccine Market Forecast by Applications (2020-2026)
13.5 Dengue Vaccine Market Forecast Under COVID-19

14 Appendix
14.1 Methodology
14.2 Research Data Source
  • FORMAT: PDF
  • PUBLISHED DATE: Jun, 2021
  • NO OF PAGES: 140